AMIC Technique for the Treatment of Chondral Injuries of the Hand and Wrist

Abstract

Scaffolds, either alone or combined with cultured chondrocyte cells, are an effective treatment for chondral or osteochondral defects of the knee and ankle joints.

Scaffolds are a more sophisticated solution and have some advantages compared with the isolated use of the more traditional treatments of microfractures or nanofractures.

In addition, scaffolds represent a less complicated technique and a less expensive treatment compared with chondrocyte culture treatments, which are accessible by very few patients.

In the present article, we detail the surgical technique and provide advices and tips for the treatment of ostecochondral hand and wrist lesions using the Chondro-Gide (Geistlich Pharma AG, Wolhausen, Switzerland) scaffold and its patented autologous matrix-induced chondrogenesis (AMIC, Geistlich Pharma AG) technique.

Keywords

osteochondral defects - AMIC technique - hand-wrist reconstructive surgery

Publication History

Received: 24 August 2021

Accepted: 01 October 2021

Article published online:
13 December 2021

• References

• 1 Benthien JP, Behrens P. The treatment of chondral and osteochondral defects of the knee with autologous matrix-induced chondrogenesis (AMIC): method description and recent developments. Knee Surg Sports Traumatol Arthrosc 2011; 19 (08) 1316-1319
• 2 Piontek T, Ciemniewska-Gorzela K, Szulc A, Naczk J, Słomczykowski M. All-arthroscopic AMIC procedure for repair of cartilage defects of the knee. Knee Surg Sports Traumatol Arthrosc 2012; 20 (05) 922-925
• 3 Behrens P. Matrixgekoppelte Mikrofrakturierung. Ein neues Konzept zur Knorpeldefektbehandlung. Arthroskopie 2005; 18 (03) 193-197
• 4 Pridie K. A method of resurfacing osteoarthritic knee joints. J Bone Joint Surg [Br] 5 1959; 41: 618-619
• 5 Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res 2001; (391, Suppl) S362-S369
• 6 Lee KB, Bai LB, Chung JY, Seon JK. Arthroscopic microfracture for osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc 2010; 18 (02) 247-253
• 7 Chuckpaiwong B, Berkson EM, Theodore GH. Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases. Arthroscopy 2008; 24 (01) 106-112
• 8 Hannon CP, Murawski CD, Fansa AM, Smyth NA, Do H, Kennedy JG. Microfracture for osteochondral lesions of the talus: a systematic review of reporting of outcome data. Am J Sports Med 2013; 41 (03) 689-695
• 9 Gobbi A, Karnatzikos G, Kumar A. Long-term results after microfracture treatment for full-thickness knee chondral lesions in athletes. Knee Surg Sports Traumatol Arthrosc 2014; 22 (09) 1986-1996
• 10 Benthien JP, Behrens P. Nanofractured autologous matrix induced chondrogenesis (NAMIC©)–Further development of collagen membrane aided chondrogenesis combined with subchondral needling: A technical note. Knee 2015; 22 (05) 411-415
• 11 Peñalver JM, Villalba J, Yela-Verdú CP. et al. All-Arthroscopic Nanofractured Autologous Matrix-Induced Chondrogenesis (A-NAMIC) Technique for the Treatment of Focal Chondral Lesions of the Knee. Arthrosc Tech 2020; 9 (06) e755-e759
• 12 Migliorini F, Eschweiler J, Maffulli N. et al. Autologous Matrix Induced Chondrogenesis (AMIC) Compared to Microfractures for Chondral Defects of the Talar Shoulder: A Five-Year Follow-Up Prospective Cohort Study. Life (Basel) 2021; 11 (03) 244 Pages 1–9 .
• 13 Valderrabano V, Miska M, Leumann A, Wiewiorski M. Reconstruction of Osteochondral Lesions of the Talus With Autologous Spongiosa Grafts and Autologous Matrix-Induced Chondrogenesis. The American Journal of Sports Medicine 2013; 41 (03) 519-527
• 14 Steinwachs M, Kreuz PC. Autologous Chondrocyte Implantation in Chondral Defects of the Knee With a Type I/III Collagen Membrane: A Prospective Study With a 3-Year Follow-up. Arthroscopy: The Journal of Arthroscopic & Related Surgery 2007; 23 (04) 381-387
• 15 Benthien JP, Behrens P. Autologous matrix-induced chondrogenesis (AMIC). A one-step procedure for retropatellar articular resurfacing. Acta Orthop Belg 2010; 76 (02) 260-263
• 16 Steinwachs MR, Gille J, Volz M, Anders S, Jakob R, De Girolamo L, Wittmann U. Systematic Review and Meta-Analysis of the Clinical Evidence on the Use of Autologous Matrix-Induced Chondrogenesis in the Knee. 2019. 1-15 CARTILAGE 194760351987084. doi:10.1177/1947603519870846
• 17 Gao L, Orth P, Cucchiarini M, Madry H. Autologous Matrix-Induced Chondrogenesis: A Systematic Review of the Clinical Evidence. Am J Sports Med 2019; Jan; 47 (01) 222-231
• 18 Becher C, Malahias MA, Ali MM, Maffulli N, Thermann H. (2018). Arthroscopic microfracture vs. arthroscopic autologous matrix-induced chondrogenesis for the treatment of articular cartilage defects of the talus. Knee Surgery, Sports Traumatology, Arthroscopy 2019; 27: 2731-2736
• 19 Kaufman D, Etcheson J, Yao J. Microfracture for Ulnar Impaction Syndrome: Surgical Technique and Outcomes with Minimum 2-Year Follow-up. Journal of Wrist Surgery 2016; 6 (01) 60-64
• 20 Kaiser N, Jacobi M, Kusano T. et al. Clinical results 10 years after AMIC in the knee. Swiss Med Wkly 2015; 145 (Suppl. 210) 43S
• 21 Gille J, Kunow J, Boisch L. et al. Cell-Laden and Cell-Free Matrix-Induced Chondrogenesis versus Microfracture for the Treatment of Articular Cartilage Defects: A Histological and Biomechanical Study in Sheep. Cartilage 2010; 1 (01) 29-42
• 22 Volz M, Schaumburger J, Frick H, Grifka J, Anders S. A randomized controlled trial demonstrating sustained benefit of Autologous Matrix-Induced Chondrogenesis over microfracture at five years. Int Orthop 2017; 41 (04) 797-804
• 23 Kramer J, Böhrnsen F, Lindner U. et al. In vivo matrix-guided human mesenchymal stem cells. Cell Mol Life Sci 2006; 63 (05) 616-626
• 24 Gomoll AH, Farr J, Gillogly SD. et al. Surgical management of articular cartilage defects of the knee. J Bone Joint Surg Am 2010; 92 (14) 2470-2490
• 25 Mumme M, Barbero A, Miot S. et al. Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial. Lancet 2016; 388 (10055): 1985-1994
• 26 Fulco I, Miot S, Haug MD. et al. Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial. Lancet 2014; 384 (9940): 337-346